Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 21:2018:1495039.
doi: 10.1155/2018/1495039. eCollection 2018.

The Portuguese Severe Asthma Registry: Development, Features, and Data Sharing Policies

Affiliations

The Portuguese Severe Asthma Registry: Development, Features, and Data Sharing Policies

Ana Sá-Sousa et al. Biomed Res Int. .

Abstract

The Portuguese Severe Asthma Registry (Registo de Asma Grave Portugal, RAG) was developed by an open collaborative network of asthma specialists. RAG collects data from adults and pediatric severe asthma patients that despite treatment optimization and adequate management of comorbidities require step 4/5 treatment according to GINA recommendations. In this paper, we describe the development and implementation of RAG, its features, and data sharing policies. The contents and structure of RAG were defined in a multistep consensus process. A pilot version was pretested and iteratively improved. The selection of data elements for RAG considered other severe asthma registries, aiming at characterizing the patient's clinical status whilst avoiding overloading the standard workflow of the clinical appointment. Features of RAG include automatic assessment of eligibility, easy data input, and exportable data in natural language that can be pasted directly in patients' electronic health record and security features to enable data sharing (among researchers and with other international databases) without compromising patients' confidentiality. RAG is a national web-based disease registry of severe asthma patients, available at asmagrave.pt. It allows prospective clinical data collection, promotes standardized care and collaborative clinical research, and may contribute to inform evidence-based healthcare policies for severe asthma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Development and implementation process of RAG.
Figure 2
Figure 2
Screenshot of the implemented automatic algorithm to determine the step of treatment, based on asthma medication according to GINA recommendations. A: treatment step calculated by the algorithm; B: the 3 criteria for patients' inclusion.
Figure 3
Figure 3
Screenshot of RAG, picturing asthma medication being collected by RAG.

Similar articles

Cited by

References

    1. GINA. Global Strategy for Asthma Management and Prevention (updated 2018). Global Initiative for Asthma. 2018.
    1. Bousquet J., Brusselle G., Buhl R., et al. Care pathways for the selection of a biologic in severe asthma. European Respiratory Journal. 2017;50(6) doi: 10.1183/13993003.01782-2017.1701782 - DOI - PubMed
    1. Zervas E., Samitas K., Papaioannou A. I., Bakakos P., Loukides S., Gaga M. An algorithmic approach for the treatment of severe uncontrolled asthma. ERS Monograph. 2018;4(1)00125 - PMC - PubMed
    1. Drazen J. M., Harrington D. New Biologics for Asthma. The New England Journal of Medicine. 2018;378(26):2533–2534. doi: 10.1056/NEJMe1806037. - DOI - PubMed
    1. Gliklich R. In: Registries for Evaluating Patient Outcomes: A User’s Guide. Dreyer N., Leavy M., editors. Rockville, Md, USA: Agency for Healthcare Research and Quality; 2014. https://www.ncbi.nlm.nih.gov/books/NBK208616/ - PubMed